chr20-63693160-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3_ModeratePP5

The NM_001283009.2(RTEL1):​c.2869C>T​(p.Arg957Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000428 in 1,612,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R957P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000044 ( 0 hom. )

Consequence

RTEL1
NM_001283009.2 missense

Scores

5
12
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:8U:3

Conservation

PhyloP100: 5.34

Publications

14 publications found
Variant links:
Genes affected
RTEL1 (HGNC:15888): (regulator of telomere elongation helicase 1) This gene encodes a DNA helicase which functions in the stability, protection and elongation of telomeres and interacts with proteins in the shelterin complex known to protect telomeres during DNA replication. Mutations in this gene have been associated with dyskeratosis congenita and Hoyerall-Hreidarsson syndrome. Read-through transcription of this gene into the neighboring downstream gene, which encodes tumor necrosis factor receptor superfamily, member 6b, generates a non-coding transcript. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
RTEL1-TNFRSF6B (HGNC:44095): (RTEL1-TNFRSF6B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RTEL1 (regulator of telomere elongation helicase 1) and TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) genes on chromosome 20. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.887
PP5
Variant 20-63693160-C-T is Pathogenic according to our data. Variant chr20-63693160-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 42021.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001283009.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RTEL1
NM_001283009.2
MANE Select
c.2869C>Tp.Arg957Trp
missense
Exon 30 of 35NP_001269938.1
RTEL1
NM_032957.5
c.2941C>Tp.Arg981Trp
missense
Exon 30 of 35NP_116575.3
RTEL1
NM_016434.4
c.2869C>Tp.Arg957Trp
missense
Exon 30 of 35NP_057518.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RTEL1
ENST00000360203.11
TSL:5 MANE Select
c.2869C>Tp.Arg957Trp
missense
Exon 30 of 35ENSP00000353332.5
RTEL1
ENST00000508582.7
TSL:2
c.2941C>Tp.Arg981Trp
missense
Exon 30 of 35ENSP00000424307.2
RTEL1
ENST00000370018.7
TSL:1
c.2869C>Tp.Arg957Trp
missense
Exon 30 of 35ENSP00000359035.3

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152082
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000401
AC:
10
AN:
249160
AF XY:
0.0000517
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000536
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000438
AC:
64
AN:
1459956
Hom.:
0
Cov.:
33
AF XY:
0.0000358
AC XY:
26
AN XY:
726274
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33474
American (AMR)
AF:
0.00
AC:
0
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26100
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86256
European-Finnish (FIN)
AF:
0.0000192
AC:
1
AN:
52070
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000459
AC:
51
AN:
1111574
Other (OTH)
AF:
0.0000829
AC:
5
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152082
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41378
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4836
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67980
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000281
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000497
AC:
6
EpiCase
AF:
0.000218
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:8Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Dyskeratosis congenita, autosomal recessive 5 Pathogenic:3
Mar 14, 2024
Baylor Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 02, 2017
Counsyl
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.

Mar 07, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Dyskeratosis congenita Pathogenic:2
Sep 16, 2020
Natera, Inc.
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 11, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: RTEL1 c.2941C>T (p.Arg981Trp), also reported as p.R734W and p.R957W, results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 4e-05 in 249160 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in RTEL1 causing Dyskeratosis Congenita (Hoyeraal Hreidarsson Syndrome) (4e-05 vs 0.0011), allowing no conclusion about variant significance. c.2941C>T has been observed in the compound heterozygous and homozygous states in multiple individual(s) affected with clinical features and/or diagnosis of Dyskeratosis Congenita (Hoyeraal Hreidarsson Syndrome) (example, Walne_2013, Touzot_2016). It has also been observed in the heterozygous state in multiple individuals with and without family history of pulmonary fibrosis (example, Borie_2019, Fang_2020). These data indicate that the variant is likely to be associated with disease. Multiple reports provide experimental evidence that this variant is associated with reduced DNA replication fork function/partner protein interaction in vitro and decreased telomere length in vivo (example, Walne_2013, Takedachi_2020, Touzot_2016). The following publications have been ascertained in the context of this evaluation (PMID: 23829372, 23453664, 24582487, 30523160, 32583532, 39279213, 32398829, 29296694). ClinVar contains an entry for this variant (Variation ID: 42021). Based on the evidence outlined above, the variant was classified as likely pathogenic.

not provided Pathogenic:1Uncertain:1
Dec 01, 2023
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed in the heterozygous state in unrelated patients with pulmonary fibrosis in published literature (PMID: 30523160, 32583532); Published functional studies demonstrate telomere shortening, increased T-circle formation, and replication fork stalling (PMID: 23453664, 29296694, 32398829); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as R957W and R734W; This variant is associated with the following publications: (PMID: 30523160, 34183866, 27415407, 28714244, 25940403, 23453664, 32583532, 29296694, 28099038, 24582487, 32398829)

Sep 27, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Pathogenic:1Uncertain:1
Oct 10, 2024
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on the classification scheme VCGS_Germline_v1.3.5, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with autosomal dominant dyskeratosis congenita 4 and autosomal recessive dyskeratosis congenita 5 (MIM#615190), and autosomal dominant pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3 (MIM#616373). (I) 0108 - This gene is associated with both recessive and dominant disease. Currently, the genotype-phenotype relationship has not been established (OMIM). (I) 0112 - The condition associated with this gene has incomplete penetrance. Monoallelic pathogenic variants have been reported in asymptomatic family members (PMID: 23329068, 25848748, 35199181). (I) 0115 - Variants in this gene are known to have variable expressivity (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v4: 69 heterozygotes, 0 homozygotes). (SP) 0309 - Multiple alternative amino acid changes at the same position have been observed in gnomAD (v4) (highest allele count: 31 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0710 - Other missense variants comparable to the one identified in this case have inconclusive previous evidence for pathogenicity. Two alternative changes, p.(Arg947Gln) and p.(Arg957Pro), have been classified as VUS by clinical laboratories in ClinVar. p.(Arg957Gln) was also observed in a large chronic hypersensitivity pneumonitis cohort (PMID: 31268371). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic by five clinical laboratories and as a VUS by two clinical laboratories in ClinVar. It has been reported in three compound heterozygous families and one homozygous individual with features consistent with autosomal recessive dyskeratosis congenita (PMIDs: 23453664, 29296694). This variant has also been identified in individuals with idiopathic pulmonary fibrosis and interstitial lung disease and has been classified as a VUS and pathogenic (personal communication, PMIDs: 30523160, 32583532). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

Jul 19, 2023
3billion
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is observed at an allele frequency greater than expected for the associated disorder in the gnomAD v2.1.1 dataset and therefore considered benign. Predicted Consequence/Location: Missense variant Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000042021). This variant has been reported to be associated with both dykeratosis congenita (PMID: 29296694) and pulmonary fibrosis (PMID: 30523160). Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline.

RTEL1-related disorder Pathogenic:1
Jan 20, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The RTEL1 c.2941C>T variant is predicted to result in the amino acid substitution p.Arg981Trp. This variant has been reported in the compound heterozygous state with a second RTEL1 variant in three unrelated patients with autosomal recessive dyskeratosis congenita (DC) and segregated with DC in all the families (Walne et al 2013. PubMed ID: 23453664). Functional studies of patient cells showed significant defects in telomere maintenance (Walne et al 2013. PubMed ID: 23453664). This variant has also been reported in the heterozygous state in three members from one family affected with autosomal dominant pulmonary fibrosis (PF) and segregated with PF in this family (referred to as p.Arg957Trp, Borie R et al 2019. PubMed ID: 30523160). This variant is reported in 0.015% of alleles in individuals of East Asian descent in gnomAD. Together we classify the c.2941C>T variant as likely pathogenic.

Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:1
Nov 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 957 of the RTEL1 protein (p.Arg957Trp). This variant is present in population databases (rs398123018, gnomAD 0.01%). This missense change has been observed in individuals with dyskeratosis congenita (PMID: 23453664). This variant is also known as c.2941C>T (p.Arg981Trp). ClinVar contains an entry for this variant (Variation ID: 42021). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Uncertain
0.054
T
BayesDel_noAF
Uncertain
0.070
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.72
D
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.78
D
MetaRNN
Pathogenic
0.89
D
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
5.3
PrimateAI
Uncertain
0.59
T
PROVEAN
Pathogenic
-6.4
D
REVEL
Uncertain
0.41
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.82
MutPred
0.57
Loss of disorder (P = 0.0476)
MVP
0.73
ClinPred
0.96
D
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.67
gMVP
0.74
Mutation Taster
=4/96
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398123018; hg19: chr20-62324513; COSMIC: COSV58890761; COSMIC: COSV58890761; API